Today: 20 March 2026
Subscribe
Browse Category

Stock Market Analysis 24 September 2025 - 5 December 2025

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

National Australia Bank (ASX:NAB) Share Price on 5 December 2025: Dividend Yield, FY25 Results and Stock Forecast

NAB shares traded at A$40.64 on Friday, up 0.3–0.4%, after falling over 10% from a November peak near A$45.25. The stock offers a 4.2% fully franked dividend yield, backed by FY25 dividends of A$1.70 per share and a CET1 ratio of 11.7%. FY25 cash earnings were A$7.09 billion, flat year-on-year and slightly below expectations. NAB trades at 18–19 times trailing earnings, above sector averages.
5 December 2025
··
Yellow Cake Plc (LON:YCA): Uranium Price Proxy With Double‑Digit Upside? Latest News, Analyst Targets and 2026 Outlook

Yellow Cake Plc (LON:YCA): Uranium Price Proxy With Double‑Digit Upside? Latest News, Analyst Targets and 2026 Outlook

Yellow Cake Plc shares traded at 531p in London on 2 December 2025, up 5.8% year-to-date. The company held 21.68 million pounds of uranium oxide worth $1.78 billion at 30 September. Shares trade at a high-single-digit discount to NAV, with prices tracking uranium markets. US OTC shares closed at $6.91, down 3.3% over ten days.
2 December 2025
···
Whitbread PLC (LON:WTB) Stock Outlook – December 2025: Budget Shock, Buybacks and a Deeply Discounted Premier Inn Giant

Whitbread PLC (LON:WTB) Stock Outlook – December 2025: Budget Shock, Buybacks and a Deeply Discounted Premier Inn Giant

Whitbread shares plunged 11% in late November after the UK Budget rewired business rates for large commercial properties, raising Whitbread’s annual bill by £40–50m from FY27. The stock closed at 2,495–2,497p on 1 December, down 12% over the year. Trading remains resilient, and the company is increasing buybacks. Analysts still issue broadly positive forecasts.
1 December 2025
··
MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

Molina Healthcare shares closed up 2.6% at $145.30 Monday on heavy volume after reports of a possible extension of ACA subsidies. The stock remains down over 50% from its 52-week high following an October earnings shock and ongoing class-action lawsuits. Market cap stood at $7.5 billion, with a P/E ratio near 9x. Intraday trading ranged from $141 to $151.
24 November 2025
·
CAVA Stock Today (23 November 2025): What Friday’s 12% Rally, New Merch Store and Gamified Loyalty Push Mean for Investors

CAVA Stock Today (23 November 2025): What Friday’s 12% Rally, New Merch Store and Gamified Loyalty Push Mean for Investors

Cava shares jumped 12.23% Friday to close at $48.92, but remain down about 66% from their 52-week high. Over 70% of shares are held by institutions. A new Simply Wall St analysis focuses on investor response to Cava’s first branded merch store and rising institutional ownership. The CAVA Pass Challenge with pro gamer Clix ends today after a five-week digital campaign.
23 November 2025
·
BJ’s Wholesale Club (BJ) Beats Q3 2025 Earnings, Raises Profit Outlook as Digital and Membership Growth Accelerate

BJ’s Wholesale Club (BJ) Beats Q3 2025 Earnings, Raises Profit Outlook as Digital and Membership Growth Accelerate

BJ’s Wholesale Club reported Q3 2025 adjusted EPS of $1.16, beating analyst forecasts but down from $1.18 a year ago. Revenue rose 4.9% to $5.35 billion, with membership fee income up 9.8% to $126.3 million. Net income slipped to $152.1 million from $155.7 million. Shares traded near $90.60, little changed after an early gain.
21 November 2025
···
Strive’s Bitcoin Bonanza: $1.3B Merger, 11K BTC and a Wild Stock Ride

ASST Stock Today: Strive Inc Slips as Hedge Fund Giant Adds Shares – What November 19, 2025 Really Means for Investors

Strive Inc. (NASDAQ: ASST) closed down about 6% at $1.05 on November 19, 2025, despite hedge fund manager Mike Alfred disclosing a purchase of 100,000 shares at around $1.05–$1.06. Trading volume reached about 65–75 million shares. The stock’s market cap hovered near $850–900 million. No new company press releases were issued during the session.
19 November 2025
·
IonQ (INBX) Stock Soars on Quantum Breakthrough and $2B Deal – Bubble or Next Big Thing?

IonQ Q3 2025 Earnings (Nov. 5): Revenue Soars 222% to $39.9M, Full‑Year Outlook Raised; Here’s What It Means for IONQ Stock

IonQ reported Q3 revenue of $39.9 million, up 222% year over year and well above expectations. The company posted a GAAP net loss of about $1.1 billion, mainly due to an $882 million non-cash warrant liability charge. Shares traded in the mid-$50s after hours. IonQ raised its 2025 revenue outlook to $106–$110 million.
5 November 2025
···
Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense (KTOS) Soars 300% on Drone Boom – Is the Rally Sustainable?

Kratos Defense shares fell to the mid-$70s after Q3 revenue beat estimates but Q4 guidance missed forecasts, cutting market cap to $13 billion. The company announced a $356.3 million cash acquisition of Israel’s Orbit Technologies and raised 2025 revenue guidance. Year-to-date, the stock is up over 300%, hitting a 21-year high in October. Analyst consensus is “Moderate Buy” with targets ranging from $77 to $125.
5 November 2025
···
Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Recursion Pharmaceuticals (RXRX) – AI Drug Discovery Breakthroughs, CEO Shakeup & 2025 Stock Outlook

Recursion Pharmaceuticals shares fell 15% in the past week to around $5, down 55% from their 52-week high. Q3 2025 revenue missed estimates at $5 million, with net loss widening to $162.3 million. The company announced a $30 million milestone payment from Roche/Genentech and a CEO transition, with Najat Khan set to take over in January. Recursion holds about $785 million in cash, enough to fund operations through 2027.
5 November 2025
··
Energy Stock on Fire: EPD’s 7% Yield and Massive Growth Plans Might Be About to Spark a Rally

Energy Stock on Fire: EPD’s 7% Yield and Massive Growth Plans Might Be About to Spark a Rally

Enterprise Products Partners declared a $0.545 per unit Q3 distribution in October 2025, marking its 27th consecutive annual payout increase. Shares trade near $31, with analysts’ average 12-month target at $35.8 and most rating it a “Buy.” Q2 distributable cash flow rose about 7% to $1.8 billion, covering payouts by 1.6 times. EPD continues major growth projects and repurchased $80 million in units during Q3.
25 October 2025
····
Palantir’s Shocking Reinvention: From Secretive Spy Tech to $400B Cult Lifestyle Brand

Palantir’s 2025 Stock Surge: AI Goldmine or Overhyped Bubble?

Palantir Technologies’ stock surged 130–140% year-to-date in 2025, topping the S&P 500 for a second year. Q2 revenue jumped 48% to $1.0 billion, driven by AI platform demand and a $10 billion U.S. Army contract. Shares trade at steep valuation multiples, with most analysts rating the stock “Hold” or “Sell.” The average 12-month price target is $15–16, below recent highs.
24 September 2025
···
1 2

Stock Market Today

  • WEX Inc. Shares Rise 3.43% on Strategic Partnerships and Strong Q4 Performance
    March 20, 2026, 5:32 PM EDT. WEX Inc. stock surged 3.43% amid renewed investor confidence driven by strategic partnership announcements and robust Q4 2025 results. The company posted an EBIT margin of 20.2% and EBITDA margin of 33%, highlighting solid operational efficiency and profitability. Despite a dip to $148.90, shares rebounded to $156.89. WEX's strong cash position of $1.68 billion and significant debt reduction of over $10.56 billion demonstrate financial stability. Analysts note the company's reasonable valuation, with a price-to-earnings ratio of 17.52 and manageable debt servicing ability. Technical indicators point to a support level near $150, suggesting potential upside if sector momentum continues. WEX's steady revenue growth and above-average returns reinforce its competitive stance in the finance sector.
Go toTop